Effects of Canagliflozin (CANA) on Kidney Outcomes: Pooled Analyses from the CANVAS Program and CREDENCE: PO0748
Levin, Adeera, Cherney, David, Wheeler, David C., Gogate, Jagadish, Haynes, Marsha, Perkovic, Vlado
Published in Journal of the American Society of Nephrology (01.10.2021)
Published in Journal of the American Society of Nephrology (01.10.2021)
Get full text
Journal Article
Evaluating Metrics Applied to the Medical Science Liaison (MSL) Role: A Survey-Based Study of Canadian MSL Leaders
Saleem, Munaza, Cesario, Lisa, Wilcox, Lisa, Haynes, Marsha, Collin, Simon, Langlois, Peter, Kenyon, Stevie, Chilelli, Andrew
Published in Therapeutic innovation & regulatory science (01.09.2021)
Published in Therapeutic innovation & regulatory science (01.09.2021)
Get full text
Journal Article
140 - Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine
Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Haynes, Marsha, Pèrez Manghi, Federico C.
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine
Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Haynes, Marsha, Pèrez Manghi, Federico C.
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
Patients with Type 2 Diabetes Treated with IDegLira Have a Greater Chance of Achieving A1C Targets Without Hypoglycemia and Weight Gain Than with Basal Insulin or Basal-Bolus Therapy, Irrespective of A1C Target
Egede, Leonard E., Bargiota, Alexandra, Cannon, Anthony J., Leiter, Lawrence A., Schiffman, Alisa, Ranthe, Mattis F., Haynes, Marsha, Doshi, Ankur
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article
19 - Patients with Type 2 Diabetes Treated with IDegLira Have a Greater Chance of Achieving A1C Targets Without Hypoglycemia and Weight Gain Than with Basal Insulin or Basal-Bolus Therapy, Irrespective of A1C Target
Egede, Leonard E., Bargiota, Alexandra, Cannon, Anthony J., Leiter, Lawrence A., Schiffman, Alisa, Ranthe, Mattis F., Haynes, Marsha, Doshi, Ankur
Published in Canadian journal of diabetes (01.10.2018)
Published in Canadian journal of diabetes (01.10.2018)
Get full text
Journal Article